Healthcare - Biotechnology - NASDAQ - US
$ 5.86
-1.51 %
$ 255 M
Market Cap
-3.31
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
227.39%
EBIT
Estimate
--50.41%
Net Income
Estimate
30.63%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Abeona Therapeutics Inc.
ABEO has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ABEO
EBIT FORECAST
EBIT Forecast Chart ABEO
NET INCOME FORECAST
Net Income Chart ABEO